Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$227.97−4.26 (-1.83%)
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Biotechnology — Biên Adjusted EBITDA by Year
Biotechnology — Biên Adjusted EBITDA (%)
Danaher Biotechnology — Biên Adjusted EBITDA: 41.4% in FY2025, up 1.5 pts from a year earlier.
Latest, FY2025
41.4%
Period ended Dec 31, 2025
Change on a year earlier
+1.5 pts
39.9% in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
Source: Danaher IR — nongaap_2025Q4 ↗
Reported in Danaher Non-GAAP Reconciliations & Supplemental Data (8-K / IR PDF).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Biotechnology — Biên Adjusted EBITDA (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 41.4% | +1.5 pts | Danaher IR — nongaap_2025Q4 ↗ |
| FY2024 | Dec 31, 2024 | 39.9% | -1.8 pts | Danaher IR — nongaap_2025Q4 ↗ |
| FY2023 | Dec 31, 2023 | 41.7% | -4.2 pts | Danaher IR — nongaap_2024Q4 ↗ |
| FY2022 | Dec 31, 2022 | 45.9% | -2.9 pts | Danaher IR — nongaap_ex_veralto ↗ |
| FY2021 | Dec 31, 2021 | 48.8% | – | Danaher IR — nongaap_ex_veralto ↗ |
Cite this data
StockData. (2026). Danaher Biotechnology — Biên Adjusted EBITDA (%), annual FY2021–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/adj-ebitda-margin-biotech
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.